Maravai LifeSciences
MRVI
MRVI
218 hedge funds and large institutions have $1.79B invested in Maravai LifeSciences in 2023 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 92 increasing their positions, 58 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $1.81B → $1.79B (-$14.7M)
16% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $1.24M
Holders
218
Holding in Top 10
1
Calls
$1.04M
Puts
$1.24M
Top Buyers
| 1 | +$36M | |
| 2 | +$28.2M | |
| 3 | +$19.4M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.3M |
| 5 |
MIIM
Mesirow Institutional Investment Management
Chicago,
Illinois
|
+$11.4M |
Top Sellers
| 1 | -$36.3M | |
| 2 | -$36.1M | |
| 3 | -$25.4M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$18.1M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$14.8M |